Coverage
-
March 06, 2015
A federal judge kept developer Mikart Inc. on the hook for allegedly costing Pisgah Laboratories Inc. $100 million in lost profits by not performing on a contract to develop an anti-abuse version of Vicodin, ruling Thursday that Pisgah presented enough evidence to overcome the dismissal motion.
1 other articles on this case.
View all »